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doi:10.1016/j.kjms.2011.11.003Abstract Acetaminophen is one of the most popular and widely used analgesics for the treat-
ment of pain and fever but few studies have evaluated its effects on neuropathic pain. This
study examined the effect of acetaminophen on thermal hyperalgesia, mechanical and cold
allodynia in a rat model of neuropathic pain. Male Sprague-Dawley rats were prepared by
tightly ligating the left L5 and L6 spinal nerves to produce a model of neuropathic pain. Sixty
neuropathic rats were assigned randomly into six groups. Normal saline and acetaminophen
(25, 50, 100, 200 and 300 mg/kg) were administered intraperitoneally to these individual
groups. Thermal hyperalgesia, mechanical and cold allodynia were examined at preadministra-
tion and at 15, 30, 60, 90, 120, 180, 240 and 360 min after administering the drug. Mechanical
allodynia was quantified by measuring the paw withdrawal threshold to stimuli with von Frey
filaments. Cold allodynia was quantified by measuring the frequency of foot lift after applying
100% acetone. Thermal hyperalgesia was quantified by measuring the thermal withdrawal
threshold. The rotarod performance was measured to detect any drug-induced adverse
effects, such as drowsiness. The hepatic and renal adverse effect was also assessed by
measuring the serum levels of aspartate aminotransferase, alanine aminotransferase, blood
urea nitrogen and creatinine. The paw withdrawal thresholds to mechanical stimuli and the
thermal withdrawal threshold were increased significantly and withdrawal frequencies to cold
stimuli were reduced by acetaminophen administration in a dose-dependent manner. Acet-
aminophen reduces thermal hyperalgesia, mechanical and cold allodynia in a rat model of
neuropathic pain, and might be useful for managing neuropathic pain.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.of Anesthesiology and Pain Medicine, School of Medicine, The Catholic University of Korea, Seoul St.
cho-Gu, Seoul 137-040, South Korea.
ac.kr (D.-E. Moon).
vier Taiwan LLC. All rights reserved.
252 K.-S. Im et al.Introduction and maintained on a 12:12-h light-dark cycle. The experi-Acetaminophen is one of the most popular and widely used
analgesics on the market. Despite its introduction into
human medicine one century ago, the mechanism for the
analgesic action of acetaminophen is not completely
understood.
Several authors have reported the antinociceptive effect
of acetaminophen in noninflammatory painmodels in healthy
animals [1e3]. Acetaminophen had a dose-dependent anti-
nociceptive effect in formalin [4,5], substance P (SP),
glutamate [6] and carrageenan [7,8] induced inflammatory
pain models. In addition, acetaminophen inhibited dose-
dependently the decrease in heat threshold in a rat thermal
hyperalgesia model [9].
It has been reported that acetaminophen does not affect
the neuropathic pain mechanism [10]. In addition, the
intrathecal administration of acetaminophen did not
attenuate the mechanical hyperalgesia in streptozocin-
induced diabetic neuropathy [11]. In the neuropathy
induced by partial ligation of the sciatic nerve, acetamin-
ophen did not significantly reduce the response to noxious
mechanical and electrical stimulation [12]. Moreover,
acetaminophen is not included in the analgesics recom-
mended in the guidelines for the treatment of neuropathic
pain [10].
However, there are reports of the positive effects of
acetaminophen in neuropathic pain. Acetaminophen
reduces mechanical allodynia in a chemotherapy-induced
neuropathic pain model [13]. Acetaminophen dose-
dependently decreases the mechanical allodynia and
thermal hyperalgesia, when administered locally in
a neuropathic pain model induced by partial ligation of the
sciatic nerve [14]. Nevertheless, the systemic anti-
nociceptive effect of acetaminophen in a neuropathic pain
model induced by the ligation of the spinal nerve has not
been profiled for the thermal hyperalgesia, mechanical and
cold allodynia.
Furthermore, there is evidence suggesting the central
analgesic effect of acetaminophen, even though the mech-
anism of the analgesic action of acetaminophen is unclear.
The suggested mechanism of the analgesic action of acet-
aminophen includes the reinforcement of the serotonergic
descending inhibitory pathway [3,4,15] and interactions with
the opioidergic system, endocannabinoid (CB) systems
[16,17], and nitric oxide (NO) containing pathways [1,18].
Therefore, this study examined the effect of the intra-
peritoneal administration of acetaminophen on thermal
hyperalgesia, mechanical and cold allodynia in a rat model
of neuropathic pain to determine if acetaminophen is a new
treatment modality for neuropathic pain diseases.
Materials and methods
Animals
All experimental procedures were approved by our insti-
tutional animal investigation committee. Male Sprague-
Dawley rats weighing 100e150 g each were used. Food
and water were provided ad libitum. The rats were housed
in groups of three to four in plastic cages with soft beddingmental rats were allowed at least 5 days to adjust to their
environment before conducting the experiment.
Spinal nerve ligation
The method reported by Kim and Chung [19] was used to
produce a neuropathic pain model by ligating the left L5
and L6 spinal nerves. The surgical procedures were per-
formed under general anesthesia delivered through an open
mask system. Anesthesia was induced by 4% Isoflurane and
maintained with 1e2% in a 1:1 mixture of nitric oxide and
oxygen at a flow rate of 2 L/min. After surgery, the rats
were allowed to recover for 7 days before starting the
behavioral tests. Those animals that showed a foot with-
drawal response to the von Frey filaments (Semmes
Weinstein Von Frey Aesthesiometers, Stoelting CO, IL, USA)
with an applied bending force of 4 g or less were considered
to be neuropathic [20e22], and they were used in the tests.
The rats that exhibited motor deficiency (such as paw
dragging or limping) or those that failed to exhibit subse-
quent mechanical allodynia were excluded.
Drug administration
Sixty neuropathic rats were divided randomly into six
groups (n Z 10 in each group) before the intraperitoneal
administration of the drugs. The intraperitoneal injections
were performed without anesthesia. The control group
received 0.9% normal saline 10 mL/kg (the NS group). There
were five experimental groups, PAR 25, PAR 50, PAR 100,
PAR 200, and PAR 300 groups, which were given 25, 50, 100,
200, and 300 mg/kg of acetaminophen in a volume of
10 mg/mL (Acetaminophen, Perfalgan, BMS Pharmaceu-
tical Korea Limited. Seoul, Korea), respectively.
Behavioral tests
To avoid circadian rhythm errors, all behavioral tests were
conducted at fixed times (1 PM to 7 PM) by the same person
who was unaware of which solution had been
administered and which dose was used. After the
intraperitoneal injection, the rats were placed on a metal
mesh covered with a plastic dome (8  8  18 cm) to assess
the mechanical and cold allodynia. Thermal hyperalgesia,
mechanical and cold allodynia were assessed before the
intraperitoneal injection and also at 15, 30, 60, 90, 120,
180, 240, and 360 min after the injection.
The thresholds for mechanical allodynia were measured
using a series of von Frey filaments (from 0.07 to 15.0 g).
The third metatarsal bone area of the left hindpaw was
stimulated with von Frey filaments at 3e4 s intervals using
the up-down method [20]. The minimal pressure (g) that
initiated a response was recorded. The threshold was
recorded as 15.0 g if the strongest hair did not elicit
a response. Avoidance responses, such as lifting, shaking or
licking the paw and running away, were considered as
positive responses.
Cold allodynia was measured as the number of foot
withdrawal responses after applying cold stimuli to the
plantar surface of the paw [23]. The tests were repeated
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each test. The response frequency to acetone is expressed
as the percentage response frequency [(number of paw
withdrawals/number of trials)  100].
Thermal hyperalgesia was measured using an increasing-
temperature hot plate (IITC life Science Inc. Victory Blvd
Woodland Hills, CA, USA) [24]. The thermal withdrawal
threshold, i.e., the lowest temperature to evoke noci-
fensive behavior, was measured. The rat was placed into
the observation chamber on the plate with a starting
temperature of approximately 30C. The plate was then
heated up at a rate of 12C/min until the animal showed
nocifensive behavior. The typical response was hindpaw
licking, while shaking and lifting of the paw or jumping was
observed on rare occasion. The cutoff temperature was set
to 50C.
The changes in locomotor function in the neuropathic
rats were evaluated by rotarod tests (Acceler rota-rod for
rats 7750; Ugo Basile, Comerio-Varese, Italy). This appa-
ratus consisted of a base platform and a rotating rod, 7 cm
in diameter, with a nonskid surface. The rod, 50 cm in
length, was divided into four equal sections by five discs
and four rats could be tested simultaneously. A V-shaped
counter-trip plate was positioned under each drum section,
26 cm below the rod on the base platform. The neuropathic
rats were acclimatized to the revolving drums, and habit-
uated to handling in order to ameliorate any stress during
the tests. The rats were given three training trials on the
revolving drums (10e15 rpm) for 2 days before the actual
day of the test. The rats were placed on the drum rotating
at 10e15 rpm. The performance time on the rod measured
until the rat fell from the drum onto the counter-trip plate
or reached a cutoff or a maximum of 150 s. The rats that
could remain on the revolving drum for a minimum of 150 s
were selected for drug testing. The mean of three training
runs served as the control performance time. The rotarod
performance time was measured at 15, 30, 60, 90, 120, 180,
240, and 360 min after an intraperitoneal injection. Each
test was performed three times at 5-min intervals, and the
mean values were compared. The tactile, cold and heat
testing all took place at the same time (i.e., each test was
repeated in order at each time interval) and only rotarod
testing was performed separately at each time interval due
to a lack of time.
Serum analysis
Approximately 1 mL of blood was collected from the tail vein
to assess the hepatic and renal adverse effects before and
24 h after the acetaminophen or normal saline injection. The
plasma was separated by centrifuging the blood for 15 min at
3000 rpm and stored at 70C until the analysis. The serum
levels of aspartate aminotransferase (AST), alanine amino-
transferase (ALT), blood urea nitrogen (BUN) and creatinine
(CREA) were measured using Hitachi 7180 Automatic Clinical
Analyzer (Hitachi high-Technologies, Japan).
Statistical analysis
The results are expressed as the mean  SEM. Statistical
analysis was performed with SPSS (version 15.0; SPSS,Chicago, IL, USA). The percentage withdrawal frequency,
withdrawal threshold and rotarod performance time were
assessed using repeated measure of analysis of the variance
(ANOVA), followed by a post hoc Dunnet’s tests for multiple
comparisons. For the dose-response curves, the withdrawal
data was converted to a percentage of the maximum
possible effect (%MPE) using the formula: %MPE for
mechanical allodynia and thermal hyperalgesia Z (post
drug threshold-baseline threshold)/(cutoff threshold-
baseline threshold)  100; %MPE for cold allodynia Z
(baseline withdrawal frequency-post drug withdrawal
frequency)/(baseline withdrawal frequency)  100. The
dose-response data was analyzed by one-way ANOVA. The
serum AST, ALT, BUN and CREA levels were analyzed by
ANOVA one-way variance, followed by a post hoc Dunnet’s
tests for multiple comparisons and a paired t test for the




After spinal nerve ligation, all the rats developed
mechanical allodynia with a paw withdrawal threshold
<2.0 g. The withdrawal threshold in the control and PAR 25
groups was not significantly different from that of the
preadministration. Compared to the preadministration
values, the withdrawal threshold in the PAR 50, PAR 100,
PAR 200 and PAR 300 groups significantly increased from 30
to 180 min, 30 to 240 min, 15 to 240 min and 15 to 240 min,
respectively. The withdrawal threshold in the PAR 25 and
PAR 50 groups was not significantly different from that of
the control group. Compared to the control group, the
withdrawal threshold in the PAR 100, PAR 200 and PAR 300
groups significantly increased from 90 to 180 min, 15 to
180 min and 15 to 240 min, respectively (Fig. 1A). The %MPE
for mechanical allodynia was 3.9  1.9, 22.8  7.5,
27.2  4.0, 31.8  8.6, and 37.5  8.3% at 25, 50, 100, 200,
and 300 mg/kg, respectively. The administration of acet-
aminophen attenuated mechanical allodynia in a dose
dependent manner (Fig. 2).
Cold allodynia
Before drug administration, all the rats showed a with-
drawal frequency from 80% to 100% when acetone was
applied, without any difference among the groups.
Compared to the preadministration values, the administra-
tion of acetaminophen reduced the withdrawal frequency
to acetone application from 90 to 120 min for the PAR 25
group, from 15 to 180 min for PAR 50, and from 15 to
240 min for the PAR 100, PAR 200, and PAR 300 groups.
Compared to the control group, the administration of
acetaminophen reduced the withdrawal frequency to
acetone application in a dose dependent manner: 120 min
for the PAR 25 group, from 30 to 180 min for PAR 50 and PAR
100 groups, and from 15 to 240 min for the PAR 200 and PAR
300 groups (Fig. 1B). The %MPE for cold allodynia was
24.5  4.0, 47.0  3.0, 53.5  3.9, 68.0  6.8 and
88.0  6.1% at 25, 50, 100, 200 and 300 mg/kg, respectively.
Figure 1. Time course of the paw withdrawal threshold to
mechanical stimuli applied to the plantar surface of the
affected left paw using von Frey filaments (A), the paw with-
drawal frequency to cold stimuli with 100% acetone (B), and
the paw thermal withdrawal threshold to heat stimuli with an
increasing-temperature hot plate (C) in a rat model of
neuropathic pain. The above parameters were measured
before (pre) and after the administration of saline (NS),
acetaminophen 25 mg/kg (PAR 25), acetaminophen 50 mg/kg
(PAR 50), acetaminophen 100 mg/kg (PAR 100), acetaminophen
200 mg/kg (PAR 200), and acetaminophen 300 mg/kg (PAR
300). The results are expressed as the mean  SEM (n Z 10 in
each group). *p < 0.05 versus the saline group by repeated
measures ANOVA and Dunnet’s test. yp < 0.05 versus the
preadministration time by repeated measures ANOVA and
Dunnet’s test.
Figure 2. Dose-response curves from the peak effects of the
percent maximal possible effect (%MPE) for mechanical and
cold antiallodynia and thermal antihyperalgesia in the acet-
aminophen groups. These curves show a dose-dependent
mechanical and cold antiallodynic and thermal anti-
hyperalgesic effect. Each line represents the mean  SEM for
10 rats. The doses (mg/kg) are represented logarithmically on
the x axis and the peak %MPE is represented on the y axis.
*P < 0.05 versus 25 mg/kg, yP < 0.05 versus 50 mg/kg,
zP < 0.05 versus 100 mg/kg, #P < 0.001 versus 200 mg/kg as
determined by one-way ANOVA.
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allodynia in a dose dependent manner (Fig. 2).
Thermal hyperalgesia
The withdrawal temperature of all neuropathic rats was
42.8  0.5C before drug administration. The withdrawal
temperature was increased by the administration of
acetaminophen reaching a maximum in 120 min after
administering drug and then returning gradually to the
preadministration level. Compared to the control group,
acetaminophen significantly increased the withdrawal
temperature from 90 to 180 min for the PAR 25 group, from
15 to 180 min for PAR 50, PAR 100 and PAR 200 groups, and
from 15 to 240 min for the PAR 300 group (Fig. 1C). The %
MPE for thermal hyperalgesia was 25.8  3.8, 40.1  2.6,
47.8  3.5, 52.8  3.9 and 70.7  3.2% at 25, 50, 100, 200
and 300 mg/kg, respectively. The administration of acet-
aminophen attenuated thermal hyperalgesia in a dose
dependent manner (Fig. 2).
Rotarod performance
The rotarod performance time was not reduced by the
administration of acetaminophen (Fig. 3).
Effect of acetaminophen administration on hepatic
and renal function
The serum AST and BUN levels were significantly higher in
the rats injected with 300 mg/kg acetaminophen than the
rats in the control and other acetaminophen groups (PAR
Figure 3. Effect of the intraperitoneal administration of acetaminophen on the rotarod performance time. The rotarod
performance time was not reduced by the administration of normal saline or acetaminophen. The results are expressed as the
mean  SEM (n Z 10 in each group).
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BUN and CREA levels were not increased in the 24 h period
after the administration of acetaminophen, except for
300 mg/kg (Fig. 4).Discussion
This study demonstrated that intraperitoneally adminis-
tered acetaminophen had a dose-dependent antiallodynic
and antihyperalgesic effect on a rat model of neuropathic
pain that did not produce sedation. This suggests that
acetaminophen may be an effective therapy for neuro-
pathic pain.
Although acetaminophen is one of the most popular and
widely used analgesics, the mechanism of the analgesic
action of acetaminophen is unclear. However, there is
evidence suggesting the central analgesic effect of acet-
aminophen. The mechanism of the analgesic action of
acetaminophen is an increase in the central nervous system
levels of serotonin released from the brainstem seroto-
nergic neurons, suggesting central mediation [3,4,15]. The
other antinociceptive mechanism of acetaminophen sug-
gested is that acetaminophen could act either directly as an
opioid or CB receptor ligand or indirectly by increasing
the endogenous opioid or CB receptor ligands [16,17]. The
metabolism of acetaminophen in the brain and in dorsal
root ganglia leads to the formation of N-(4-hydroxyphenyl)-
arachidonylamide (AM404), which inhibits the cellular
reuptake of CB [16]. In addition, the suggested mechanisms
of the analgesic action include the inhibition of prosta-
glandin synthesis [25e27], and an interaction with the NO
containing pathways [1,18]. Therefore, the systemic
administration of acetaminophen was used to evaluate the
antinociceptive effect on a rat model of neuropathic pain in
the present study.Acetaminophen administered orally (200, 400 and
800 mg/kg), intravenously (50, 100, 200 and 300 mg/kg) and
intrathecally (100 and 200 mg/rat) induced a significant
dose-dependent antinociceptive effect in the paw-pressure
test [2]. The intraperitoneal administration of acetamino-
phen (400 mg/kg) also had an antinociceptive effect in the
hot-plate test [1]. In addition, acetaminophen had a signif-
icant antinociceptive effect in an inflammatory pain model
in rats [4e8]. Pini et al. [4] reported that the intraperito-
neal administration of acetaminophen had a significant
antinociceptive effect in the formalin test at a dose of
300 mg/kg. In another study, the oral administration of
acetaminophen (200 and 300 mg/kg) dose-dependently
inhibited the nociceptive behavior in both phases of the
formalin test and reduced the intrathecal SP and
glutamate-induced nociceptive behavior [6].
However, the antinociceptive effect of acetaminophen
in neuropathy is controversial. Lynch et al. [13] reported
that the oral administration of acetaminophen attenuated
the mechanical allodynia in a rat chemotheraphy-induced
neuropathic pain model but neither cold allodynia nor
thermal hyperalgesia was assessed in that study. The local,
not systemic administration of acetaminophen decreased
the mechanical allodynia and thermal hyperalgesia in the
neuropathic pain model by partial ligation of the sciatic
nerve [14]. Unlike the present study, their study evaluated
the local peripheral effect of acetaminophen but did not
examine cold allodynia.
In contrast, there are some reports showing that acet-
aminophen lacks the antinociceptive activity in experi-
ments performed in neuropathy [12,28] and does not affect
the neuropathic pain mechanisms [10]. The intrathecal
administration of acetaminophen did not increase the paw
withdrawal threshold to mechanical stimulation at a dose
of 1e7 mg in streptozotocin-induced diabetic neuropathic
pain model in rats [11]. Curros-Criado et al. [12] reported
Figure 4. Effect of the intraperitoneal administration of
acetaminophen on the hepatic. (A) and the renal functional
enzymes (B). Serum AST, ALT, BUN and CREA levels were
measured before (pre) and at 24 h after drug administration.
The serum AST, ALT, BUN and CREA levels were not elevated
with the administration of acetaminophen, except at 300 mg/
kg. The results are expressed as the mean  SEM(n Z 10 in
each group). *p < 0.05 versus the saline group by one-way
measures ANOVA and Dunnet’s test. yp < 0.05 versus the pre-
administration time by paired t test.
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not reduce the response to noxious mechanical and elec-
trical stimulation in the neuropathic pain model by partial
ligation of the sciatic nerve. These results are inconsistent
with those of the present study. Kim et al. [29] compared
three animal models of neuropathic pain and reported that
mechanical allodynia in the spinal nerve ligation neuro-
pathic pain model was greater than in the partial sciatic
nerve ligation neuropathic pain model but reduced more
after the sympathectomy. In addition, the number and
types of injured fibers in the partial sciatic nerve ligation
neuropathic pain model are difficult to control [19].
Therefore, the number and types of sciatic nerve axons
ligated also differ from experiment to experiment due to
the inability to damage precisely the same part of the nerve
in each animal. On the other hand, the present surgical
procedure tightly ligates the same spinal nerves in each
animal. Therefore, the only potential variability between
experimental subjects would be the differences between
individual rats in the proportion of the sciatic nerve
contributed by its three spinal segments, which is normalbiological (not experimental) variability. The streptozotocin-
induced diabetic neuropathic pain model was also different
from the spinal nerve ligation neuropathic pain model,
which produces both mechanical allodynia and thermal
hyperalgesia ipsilaterally to the lesion. The streptozotocin-
induced diabetic neuropathic pain model in rats produces
long-lasting mechanical allodynia, but the thermal hyper-
algesia is variable [11,30,31]. In addition, diabetic animals
are chronically ill, with a reduced growth rate, polyuria,
diarrhea and show markedly reduced motor activity.
Therefore, there is some doubt as to whether the changes
in the nocifensive reflex activity, which is used as a measure
of allodynia, are genuinely indicative of peripheral
neuropathy or can be attributed to the poor health of the
animals. Moreover, the mechanical hyperalgesia is largely
resistant to a range of pharmacological tools [30]. The
profound ill-health of the animals, together with the poor
activity of a range of potential analgesic drugs, may raise
these questions. Therefore, these differences in pain
models might be related to the discrepancy of the results.
In addition, the discrepancy of the results might be
related to the difference in animals (Male Sprague-Dawley
rats, initially weighing 200e230 g vs. Male Wistar rats
weighing 235e350 g vs. Male Sprague-Dawley rats weighing
100e150 g). Different strains of rats show different
neuropathic pain behaviors [32,33]. Compared to Sprague-
Dawley rats, Wistar rats showed generally low frequencies
of foot withdrawals to repeated mechanical stimuli with
the von Frey filament in the spinal nerve ligation neuro-
pathic pain model [32]. The age and size of the rats also
affects the development of allodynia in the neuropathic
pain model [34e36]. Young rats displayed much more
vigorous behavioral signs of mechanical allodynia and
ongoing pain after ligation of spinal nerve than the old rats
[35]. Finally, the difference in the route of drug adminis-
tration (intrathecal vs. intraperitoneal), or the types of
nociceptive stimulation used in these studies might also
explain the discrepancy of the results. Curros-Criado et al.
[12] reported that the highest dose (960 mmol/kg) of ace-
tominophen administered intravenously decreased the
response to electrical stimulation, but the intrathecal
administration of acetominophen did not reduce the
response to electrical stimulation. The intrathecal and
intravenous administration of acetaminophen did not
reduce the response to noxious mechanical in their study.
Acetaminophen was reported to induce drowsiness [16].
In animal behavioral tests, drowsiness after drug adminis-
tration may reduce the response to stimulation and mimic
the antiallodynic and antihyperalgesic effects. A rotarod
test was performed to examine the effect of acetamino-
phen on the motor coordination to exclude drowsiness-
induced antiallodynic and antihyperalgesic effect. The
experimental rats did not show a significant decrease in
rotarod performance. Therefore, the antiallodynic and
antihyperalgesic effects produced by 25e300 mg/kg acet-
aminophen were not caused by drug-induced drowsiness.
Acetaminophen also has an effect on the hepatic and renal
function. Therefore, the serum AST, ALT, BUN and CREA
levels were measured before and 24 h after the acet-
aminophen injection. Twenty-four hours was chosen as
a time point because preliminary experimental results
showed the highest AST, ALT, BUN and CREA levels at 24 h
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BUN and CREA levels were not increased at 24 h after the
administration of acetaminophen. The acetaminophen
doses administered in the present study were within the
range used by others in comparable studies [1,5,7]. The
400 mg/kg dose of acetaminophen administered intraperi-
toneally is a subtoxic level in rats and the motor activities
also remained unchanged by such doses [1]. Only the
highest dosed (300 mg/kg) rats showed an elevation of the
serum AST, ALT, BUN and CREA levels.
Acetaminophen is not recommended in the guidelines
for the treatment of the neuropathic pain. The analgesic
effects of acetaminophen, alone or combination with other
analgesics, on neuropathic pain have been rarely reported
in published clinical trials [37,38]. Gulcu et al. [37] sug-
gested that an acetaminophen infusion in a dose of 4 g/day
might be effective for neuropathic pain. The combination
of oxycodone 5 mg and acetaminophen 325 mg at up to 8
hour intervals improved the level of pain in patients with
neuropathic pain [38], and tramadol 37.5 mg/acetamino-
phen 325 mg combination tablets with a maximal dose of
four tablets per day were effective in the treatment of
chronic lower back pain [39]. Based on these published
clinical trials and the current animal experiments, acet-
aminophen, alone or combination with other drugs may
suitable for treating neuropathic pain but further studies
will be needed in a clinical setting.
In conclusion, intraperitoneally administered acetamin-
ophen had a dose-dependent antiallodynic and anti-
hyperalgesic effect in this neuropathic rat model. In
addition, the administration of acetaminophen at 200 mg/
kg or below does not increase the serum AST, ALT, BUN and
CREA levels. This study shows that acetaminophen may be
a treatment modality for a broad range of neuropathic pain
diseases that are accompanied by allodynia or hyperalgesia.
However, proper human clinical trials will be needed to
confirm similar responses in the human population.References
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